tiprankstipranks
NRX Pharmaceuticals (NRXP)
NASDAQ:NRXP
US Market
NRXP
NRX Pharmaceuticals
RESEARCH TOOLSreports
Want to see NRXP full AI Analyst Report?

NRX Pharmaceuticals (NRXP) Income Statement

882 Followers

NRX Pharmaceuticals Income Statement

Last quarter (Q4 2025), NRX Pharmaceuticals's total revenue was $983.00K, an increase of Infinity% from the same quarter last year. In Q4, NRX Pharmaceuticals's net income was $360.00K. See NRX Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Dec 22Mar 22
Total Revenue
$ 1.23M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 577.00K$ -5.00K$ -5.00K$ -4.00K$ -2.00K
Operating Expenses
$ 16.77M$ 19.70M$ 27.58M$ 44.33M$ 95.20M
Depreciation and Amortization
$ 143.00K$ 5.00K$ 5.00K$ 4.00K$ 2.00K
EBITDA
$ -16.04M$ -24.04M$ -30.02M$ -39.75M$ -93.04M
Operating Income
$ -16.22M$ -19.70M$ -27.59M$ -44.34M$ -95.20M
Other Income/Expenses
$ -12.40M$ -5.42M$ -2.56M$ 4.58M$ 2.14M
Pretax Income
$ -28.62M$ -25.13M$ -30.15M$ -39.75M$ -93.06M
Net Income
$ -28.62M$ -25.13M$ -30.15M$ -39.75M$ -93.06M
Per Share Metrics
Basic EPS
$ -1.34$ -2.39$ -3.98$ -0.60$ -7.44
Diluted EPS
$ -1.34$ -2.39$ -3.98$ -0.60$ -7.44
Weighted Average Shares Outstanding
 21.40M 10.52M 7.58M 65.77M 46.92M
Weighted Average Shares Outstanding (Diluted)
 21.40M 10.52M 7.58M 65.77M 46.92M
Currency in USD

NRX Pharmaceuticals Earnings and Revenue History